Potential mechanisms of low sodium diet-induced cardiac disease: Superoxide-NO in the heart

Circulation Research

Volumn 106, Issue 3, 2010, Pages 593-600

  Suematsu, Nobuhiro ^a   Ojaimi, Caroline ^a   Recchia, Fabio A ^a   Wang, Zipping ^a   Skayian, Yester ^a   Xu, Xiaobin ^a   Zhang, Suhua ^a   Kaminski, Pawel M ^a   Sun, Dong ^a   Wolin, Michael S ^a   Kaley, Gabor ^a   Hintze, Thomas H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Angiotensin II; Free radicals; Heart diseases; Low salt diet; Nitric oxide

Indexed keywords

ANGIOTENSIN II; APOCYNIN; ASCORBIC ACID; BRADYKININ; CEVADINE; FATTY ACID; GLUCOSE; LUCIGENIN; NITRIC OXIDE; PROTEIN P47; PROTEIN P47PHOX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE; TEMPOL; TIRON; UNCLASSIFIED DRUG;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHEMOLUMINESCENCE; CONTROLLED STUDY; DOG; ENERGY METABOLISM; HEART DISEASE; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE OXYGEN CONSUMPTION; HEMODYNAMICS; IN VITRO STUDY; MALE; MEAN ARTERIAL PRESSURE; MICROARRAY ANALYSIS; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RNA ISOLATION; SODIUM RESTRICTION; WESTERN BLOTTING;

ACETOPHENONES; ANGIOTENSIN II; ANIMALS; ASCORBIC ACID; CORONARY VESSELS; DIET, SODIUM-RESTRICTED; DOGS; FATTY ACIDS; GENE EXPRESSION PROFILING; GLUCOSE; HEMODYNAMICS; INFUSIONS, INTRAVENOUS; LACTATES; MALE; MYOCARDIUM; NADPH OXIDASE; NITRIC OXIDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; OXYGEN CONSUMPTION; RENIN-ANGIOTENSIN SYSTEM; SUPEROXIDES; VASODILATION; VERATRINE; WEIGHT LOSS;

EID: 77649153789     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.208397     Document Type: Article

References (51)

1. Braunwald E, ed. Heart Disease. Philadelphia, Pa: WB Saunders; 1980 1836-1837.
2. Berne RM, Levy MN, eds. Cardiovascular Physiology. 4th ed. St Louis, Mo: Mosby Inc; 1998 729-734.
3. Luchner A, Stevens TL, Borgeson DD, Redfield MM, Bailey JE, Sandberg SM, Heublein DM, Burnett JC Jr. Angiotensin II in the evolution of experimental heart failure. Hypertension. 1996;28:472-477.
4. Connel EM, Kaley G. Evidence for the presence of renin in kidneys of marine fish and amphibia. Biol Bull. 1964;127:366-368.
5. Griendling K, Sorescu D, Ushio-Fukai M. NADPH oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494-501.
6. Laursen JB, Rajagopalan S, Galis S, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 1997;95:557-559.
7. Kinugawa S, Post H, Kaminski PM, Zhang XP, Xu XB, Huang H, Recchia FA, Ochoa M, Wolin MS, Kaley G, Hintze TH. Coronary microvascular stunning after acute pressure overload in conscious dogs is caused by oxidant processes: the role of angiotensin II type 1 receptor and NAD(P)H oxidase. Circulation. 2003;108:2934-2940.
8. Tada H, Thompson CI, Recchia FA, Loke KE, Ochoa M, Smith CJ, Shesely EG, Kaley G, Hintze TH. Myocardial glucose uptake is regulated by nitric oxide via endothelial nitric oxide synthase in Langendorff Mouse heart. Circ Res. 2000;86:270-274.
9. phox-containing NADPH oxidase medicates attenuation of nitric oxide-dependent control of myocardial oxygen consumption by Angiotensin II. Am J Physiol. 2005;289:H862-H867.
10. Ivanoski O, Szumilak D, Nguyen-Khoa T, Dechaux M, Massy ZA, Phan O, Mothu N, Lacour B, Drueke TB, Muntzel M. Dietary salt intake accelerates atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis. 2005;180: 271-276. (Pubitemid 41072896)
11. Alderman MH, Cohen K, Madhavan S. Dietary sodium intake and mortality: National Health and Nutrition Examination Survey (NHANES). Lancet. 1998;351:1508-1509;352: 987-988.
12. Alderman MH, Madhavan S, Cohen H, Sealy JE, Laragh JH. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension. 1995;27:1153-1154.
13. Alderman MH. Dietary sodium and cardiovascular health in hypertensive patients: the case against sodium restriction. J Am Soc Nephrol. 2004;15: (suppl 1):S47-S50.
14. Alderman MH, Cohen HW. Impact of dietary sodium on cardiovascular disease mortality and morbidity. Curr Hypertens Rep. 2002;4:453-457.
15. Adler A, Messina E, Sherman B, Wang Z, Huang H, Linke A, Hintze TH. NAP(P)H oxidase generated superoxide anion accounts for reduced control of myocardial oxygen consumption by NO in aged Fischer 344 rats. Am J Physiol. 2003;285:H1015-H1022.
16. Mital S, Loke KE, Addonizio L, Oz M, Hintze TH. Left ventricular assist device preserves nitric oxide dependent control of mitochondrial respiration in failing human hearts. J Am Coll Cardiol. 2000;36:1897-1902.
17. 2 consumption in the nonhuman primate: an additional mechanism of action of amlodipine. Am J Physiol. 1999;276:H2069-H2075.
18. Loke KE, Messina E, Mital S, Hintze TH. Impaired nitric oxide modulation of myocardial oxygen consumption in genetically cardiomyopathic hamster. J Molec Cell Cardiol. 2000;32:2299-2306.
19. Chen HH, Redfield MM, Nordstrom LJ, Cataliotti A, Burnett JC. Angiotensin II AT1 receptor antagonism prevents the detrimental renal actions of acute diuretic therapy in human heart failure. Am J Physiol. 2003;284:F1115-F1119.
20. Greenburg A. Diuretic complications. Am J Med Sci. 2000;319:10-24.
21. Zafari AM, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison DG, Taylor WR, Griendling KK. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II induced vascular hypertrophy. Hypertension. 1998;32:488-495.
22. Fukai T, Siegfried MR, Ushio-Fukai M, Griendling KK, Harrison DG. Modulation of extracellular superoxide dismutase expression by angio-tensin II and hypertension. Circ Res. 1999;85:23-28.
23. Aviv A. Salt consumption, reactive oxygen species and cardiovascular ageing: a hypothetical link. J Hyperten. 2002;20:555-559.
24. Zhao G, Zhang X, Smith CJ, Xu X, Ochoa M, Greenhouse D, Vogel T, Curran C, Hintze TH. Reduced coronary NO production in conscious dogs after the development of alloxan-induced diabetes. Am J Physiol. 1999;277:H268-H278.
25. Zhao G, Zhang X, Xu X, Ochoa M, Hintze TH. Exercise training enhances reflex cholinergic, NO dependent coronary vasodilation in conscious dogs. Circ Res. 1997;80:868-876.
26. Williams JG, Rancon-Skinner T, Sun D, Wang Z, Zhang S, Zhang X, Hintze TH. Role of nitric oxide in the coupling of myocardial oxygen consumption and coronary vascular dynamics during pregnancy in the dog. Am J Physiol. 2007;293:H2479-H2486.
27. Williams JG, Ojaimi C, Qanud K, Zhang S, Xu X, Recchia FA, Hintze TH. Coronary nitric oxide production controls cardiac substrate metabolism during pregnancy in the dog. Am J Physiol. 2008;294:H2516-H2423.
28. Shen W, Ochoa M, Xu X, Wang J, Hintze TH. Role of EDRF/NO in parasympathetic coronary vasodilation following carotid chemoreflex activation in conscious dogs. Am J Physiol. 1994;267:H605-H613.
29. Suematsu N, Ojaimi C, Kinugawa S, Wang Z, Xu X, Koller A, Recchia FA, Hintze TH. Hyperhomocysteinemia alters cardiac substrate metabolism by impairing nitric oxide bioavailability through oxidative stress. Circulation. 2007;115:255-262.
30. Gerritsen M, Printz M. Sites of prostaglandin synthesis in the bovine heart and isolated coronary microvessels. Circ Res. 1981;49:1152-1163.
31. Zhang X, Hintze TH. Amlodipine releases nitric oxide from canine coronary microvessels-an unexpected mechanism of action of a calcium channel-blocking agent. Circulation. 1998;97:576-580.
32. Ojaimi C, Qanud K, Hintze TH, Recchia FA. Altered expression of a limited number of genes contributes to cardiac decompensation during chronic ventricular tachypacing in dogs. Physiol Genomics. 2006;29:76-83.
33. Recchia FA, Osorio JC, Chandler MP, Xu X, Panchal AR, Lopashuk GD, Hintze TH, Stanley WC. Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs. Am J Physiol. 2002;282:E197-E206.
34. Lei B, Lionetti V, Young ME, Chandler MP, d'Agnostino C, Kang E, Altarejos M, Matsuo K, Stanley WC, Hintze TH, Recchia FA. Paradoxical downregulation of glucose oxidation pathway despite enhanced flux in heart failure. J Mol Cell Cardiol. 2004;36:567-576.
35. Omvik P, Lund-Johansen P. Is sodium restriction effective treatment of borderline and mild essential hypertension? A long-term hemodynamic study at rest and during exercise. J Hypertens. 1986;4:535-541. (Pubitemid 17201849)
36. Zhao G, Shen W, Xu X, Ochoa M, Bernstein R, Hintze TH. Selective impairment of vagally mediated, nitric oxide-dependent coronary vaso-dilation in conscious dogs after pacing-induced heart failure. Circulation. 1995;91:2655-2663.
37. Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophy Res Commun. 1998;157:87-94.
38. Granger DL, Lehninger AL. Sites of inhibition of mitochondrial electron-transport in macrophage injured neoplastic cells. J Cell Biol. 1982;85:527-535.
39. Clementi E, Brown GC, Foxwell N, Moncada S. On the mechanism by which vascular endothelial cells regulate their oxygen consumption. Proc Natl Acad Sci USA. 1999;96:1559-1562.
40. Victor VM, Nunez C, D'Ocon P, Taylor CT, Esplugues JV, Moncada S. Regulaton of oxygen distribution in tissues by endothelial nitric oxide. Circ Res. 2009;104:1178-1183.
41. Pechanova O, Jendekovi L, Vrankova S. Effect of chronic apocynin treatment on nitric oxide and reactive oxygen species production in borderline and spontaneous hypertension. Pharmacol Rep. 2009;61:116-122.
42. Huemuller S, Wind S, Barbosa-Sicard E, Schmidt HHHW, Busse R, Schroder K, Brandes RP. Apocynin is not an inhibitor of vascular NADPH oxidase but an antioxidant. Hypertension. 2008;51:211-217.
43. Recchia FA. Role of nitric oxide in the regulation of substrate metabolism in heart failure. Heart Fail Rev. 2002;7:141-148.
44. Recchia FA, McConnell PI, Bernstein RD, Vogel TR, Xu X, Hintze TH. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res. 1998;83:969-979.
45. Depre C, Hue L. Cyclic GMP in the perfused rat heart: effects of ischemia, anoxia and nitric oxide synthase inhibitor. FEBS Lett. 1994;345:241-245.
46. Depre C, Vanoverscheltd JLJ, Goudemart JF, Mottet I, Hue L. Protection against ischemic injury by non-selective nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation. 1995;92:1911-1918.
47. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neuro-degenerative diseases. FEBS Lett. 1994;345:50-54.
48. Depre C, Gaussin V, Ponchaut N, Fisher Y, Vanoverschelde JLJ, Hue L. Inhibition of myocardial glucose uptake by cGMP. Am J Physiol. 1998; 274:H1443-H1449.
49. Bernstein RW, Ochoa FY, Xu X, Forfia P, Shen W, Thompson CI, Hintze TH. Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ Res. 1996;79:840-848. (Pubitemid 26317833)
50. Trochu J, Bouhour J, Kaley G, Hintze TH. Role of endothelium-derived nitric oxide in the regulation of cardiac oxygen metabolism. Circ Res. 2000;87:1108-1117.
51. Cohen HW, Hailpern SM, Alderman MH. Sodium intake and mortality follow-up in the Third National Health and Nutrition Examination Survey (NHANES III). J Gen Med. 2008;23:1537-1538.